Почетна › Леукемија › Њујорк › New York City
Kliničke studije za Леукемија u gradu New York City, NY
Jedna studija za Леукемија traži učesnike na lokaciji u gradu New York City ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Тражи се учесникФаза 3
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
- Weill Cornell Medical Center, New York
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Тражи се учесникФаза 2
- Columbia University Medical Center New York Presbyterian, New York
A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Тражи се учесникОпсервациона студија
- Mount Sinai Hospital, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of Revumenib and Mezigdomide in People With Leukemia
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Тражи се учесникФаза 1/2
- Research Site, New York
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Тражи се учесникФаза 1/2
- Montefiore Medical Center, New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Тражи се учесникФаза 2/3
- Perlmutter Cancer Center - 34th Street, New York
- Icahn School of Medicine at Mount Sinai, New York
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Тражи се учесникФаза 2
- Weill Cornell, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College-NY Presbyterian Hospital, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Тражи се учесникФаза 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
CD4CAR for CD4+ Leukemia and Lymphoma
Тражи се учесникФаза 1
- Albert Einstein Health Network, New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Тражи се учесникФаза 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Тражи се учесникЗдраве особе су добродошле
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Тражи се учесникФаза 1
- New York - Presbyterian / Weill Cornell Medicine, New York
- Mount Sinai - Ruttenberg Treatment Center, New York
- Columbia University Medical Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, New York
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Studije za Леукемија u drugim gradovima
- Houston, TX31 студија
- Boston, MA27 студија
- Chicago, IL19 студија
- Los Angeles, CA17 студија
- Durham, NC14 студија
- Baldwin Park, CA14 студија
- Nashville, TN13 студија
- Columbus, OH13 студија
- Philadelphia, PA13 студија
- Atlanta, GA12 студија
- Milwaukee, WI12 студија
- Seattle, WA12 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.